Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for the Prevention of Postpartum Smoking Relapse
NCT04098874Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Jan 2020
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by University of Minnesota. Started Jan 2020; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04098874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098874.